MedTrace Logo

Wormwood in Chronic Progressive Disorders With Reduced Appetite

NCT01126931 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2010-05-20

No results posted yet for this study

Summary

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer.

Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite

Conditions

Sponsors & Collaborators

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Simone S Krebs, MD, PhD · University of Freiburg, Nuclear Medicine, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2012-08-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01126931 on ClinicalTrials.gov